Sustained remission of multi-line relapsed extranodal NK/T-cell lymphoma, nasal type, following sintilimab and chidamide-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sustained remission of multi-line relapsed extranodal NK/T-cell lymphoma, nasal type, following sintilimab and chidamide

Published:2021-03-12 Issue:10 Volume:100 Page:e24824
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Xu Jingyan,Xu Xihui,Chen Jieyu,Wang Jing,Jiang Chong,Lv Chenglan,Chen Bing

Funder

Nanjing Medical Science and Technique Development Foundation

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference15 articles.

1. Distribution pattern of lymphoma subtypes in China: a nationwide multicenter study of 10 002 cases [J];Li;J Diagn Concepts Pract,2012

2. Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study;Lee;J Clin Oncol,2006

3. Beyond first-line non-anthracycline-based chemotherapy for extranodal NK/T-cell lymphoma: clinical outcome and current perspectives on salvage therapy for patients after first relapse and progression of disease;Lim;Ann Oncol,2017

4. Sintilimab for relapsed/refractory (r/r) extranodal NK/T cell lymphoma (ENKTL): Extended follow-up on the multicenter, single-arm phase II trail (ORIENT-4);Li;Journal of Clinical Oncology,2020

5. Combination therapy with histone deacetylase inhibitors (HDACi) for the treatment of cancer: achieving the full therapeutic potential of HDACi;Suraweera;Front Oncol,2018

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of PD-1 blockade in refractory/relapsed natural killer T-cell lymphomas: a systematic review and synthesis of case reports;Leukemia & Lymphoma;2023-10-05

2. Epigenetic alterations and advancement of lymphoma treatment;Annals of Hematology;2023-08-15

3. Intensive therapy can improve long‐term survival in newly diagnosed, advanced‐stage extranodal NK/T‐cell lymphoma: A multi‐institutional, real‐world study;International Journal of Cancer;2023-08-04

4. Rational Targets of Therapy in Extranodal NK/T-Cell Lymphoma;Cancers;2023-02-21

5. Deep remission from induction chemotherapy predicts favorable long-term survivals in early stage extranodal nasal NK/T-cell lymphoma receiving sequential chemotherapy and radiation;Aging;2022-11-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3